CLINICAL_TRIALS
trial_result
· 2017-03-03
Clinical Trial Update: Exalenz Lab Mode System Compared to Biopsy for H.Pylori Detection [Phase 3]
Summary
Phase 3 trial update comparing Exalenz Lab Mode System to biopsy for detecting Helicobacter pylori; study completed with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Meridian Bioscience, Inc. | Conditions: Helicobacter Pylori Infection | Phase 3 | Status: COMPLETED | Results posted: 2017-03-03